Starpharma Holdings Limited (SPL.AX)
AUD 0.09
(0.0%)
AUD 0.09
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 2.4 Million AUD | -13.16% |
| 2023 | 2.77 Million AUD | -1.81% |
| 2022 | 2.82 Million AUD | 64.09% |
| 2021 | 1.72 Million AUD | 248.38% |
| 2020 | 494 Thousand AUD | 23.81% |
| 2019 | 399 Thousand AUD | 0.0% |
| 2018 | - AUD | -100.0% |
| 2017 | 1.00 AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 1.00 AUD | 0.0% |
| 2014 | - AUD | -100.0% |
| 2013 | 1.00 AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 100.0% |
| 2008 | -370 Thousand AUD | 15.11% |
| 2007 | -435.84 Thousand AUD | -171.65% |
| 2006 | -160.44 Thousand AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | -100.0% |
| 2002 | 104.61 Thousand AUD | 48556.74% |
| 2001 | 215.00 AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q4 | 2.4 Million AUD | 0.0% |
| 2024 Q2 | 2.7 Million AUD | 0.0% |
| 2024 FY | 2.4 Million AUD | -13.16% |
| 2023 Q4 | 2.77 Million AUD | 0.0% |
| 2023 Q2 | 2.81 Million AUD | 0.0% |
| 2023 FY | 2.77 Million AUD | -1.81% |
| 2022 Q4 | 2.82 Million AUD | 0.0% |
| 2022 Q2 | 1.89 Million AUD | 0.0% |
| 2022 FY | 2.82 Million AUD | 64.09% |
| 2021 Q4 | 1.72 Million AUD | 0.0% |
| 2021 FY | 1.72 Million AUD | 248.38% |
| 2021 Q2 | 701 Thousand AUD | 0.0% |
| 2020 FY | 494 Thousand AUD | 23.81% |
| 2020 Q2 | 275 Thousand AUD | 0.0% |
| 2020 Q4 | 494 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | 399 Thousand AUD | 0.0% |
| 2019 FY | 399 Thousand AUD | 0.0% |
| 2018 Q2 | 1.00 AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | -100.0% |
| 2017 FY | 1.00 AUD | 0.0% |
| 2017 Q4 | 1.00 AUD | 0.0% |
| 2017 Q2 | 1.00 AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | -100.0% |
| 2015 FY | 1.00 AUD | 0.0% |
| 2015 Q4 | 1.00 AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2014 FY | - AUD | -100.0% |
| 2014 Q2 | 1.00 AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2013 Q2 | 1.00 AUD | 0.0% |
| 2013 Q4 | 1.00 AUD | 0.0% |
| 2013 FY | 1.00 AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 Q3 | - AUD | -100.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | 100.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | -370 Thousand AUD | 15.11% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | -435.84 Thousand AUD | -171.65% |
| 2006 FY | -160.44 Thousand AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | -100.0% |
| 2002 FY | 104.61 Thousand AUD | 48556.74% |
| 2002 Q4 | 47.49 Thousand AUD | 0.0% |
| 2001 Q4 | 12.77 Thousand AUD | 0.0% |
| 2001 FY | 215.00 AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | 243.374% |
| Acrux Limited | 147 Thousand AUD | -1538.095% |
| Actinogen Medical Limited | 108.82 Thousand AUD | -2112.646% |
| AnteoTech Limited | 221.85 Thousand AUD | -985.384% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 458.818% |
| Alterity Therapeutics Limited | 1.00 AUD | -240799900.0% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -2379.484% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Biome Australia Limited | 1.88 Million AUD | -27.503% |
| Biotron Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | -99.111% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 8.93 Billion AUD | 99.973% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 77.34% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | -2125.426% |
| Dimerix Limited | - AUD | -Infinity% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | -71.853% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 374.497% |
| Immuron Limited | 1.58 Million AUD | -51.962% |
| Immutep Limited | 2.00 AUD | -120399900.0% |
| Imugene Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 2635.191% |
| Memphasys Limited | 164.76 Thousand AUD | -1361.511% |
| Nanollose Limited | - AUD | -Infinity% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 202.067% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | -104.651% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | -17.99 Million AUD | 113.381% |
| Race Oncology Limited | 16.4 Thousand AUD | -14582.032% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 343.87% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 86.089% |
| Tissue Repair Ltd | 214.72 Thousand AUD | -1021.45% |
| Zelira Therapeutics Limited | 1.25 Million AUD | -92.285% |